Advertisement

International Ophthalmology

, Volume 34, Issue 1, pp 69–74 | Cite as

The study of etiological and demographic characteristics of pterygium recurrence: a consecutive case series study from Pakistan

  • P. Salim Mahar
  • Nabeel ManzarEmail author
Original Article

Abstract

To determine the agents of recurrence, the demographic features, and the management and outcomes of pterygium cases treated at Aga Khan University Hospital (AKUH), Karachi. This hospital-based descriptive study included 147 patients with pterygium (147 eyes) from both sexes, who presented at the Ophthalmology Department at AKUH between January 1, 2002 and December 31, 2010. Data regarding their demographic profile and other factors were collected in a well-structured proforma. Data were analyzed using frequencies, proportions, group means, standard deviations, and Pearson’s chi squared test. The male to female ratio in our study was 2:1, with factors such as younger age (<50 years) at presentation (P = 0.04, Pearson’s chi squared test) and the presence of secondary pterygium (P = 0.050) correlated significantly with the recurrence of pterygium. There was a definite trend of decreased recurrence seen with lower grade of pterygium (P = 0.06). The recurrence rate in our study was 8.8 %. These results suggest that a younger age coupled with a higher grade of pterygium as well as a history of multiple recurrences leads to increased susceptibility of recurrence after surgical excision. Early diagnosis and appropriate management will lead to a better prognosis.

Keywords

Pterygium Recurrence Pterygium grade Etiologic factors Age 

Notes

Acknowledgments

The authors are greatly indebted to Dr. Tashfeen Ahmad, Associate Professor, Department of Surgery, AKUH for his assistance in statistical analysis.

Conflict of interest

No conflicting relationship exists for any author.

Financial Support

None.

References

  1. 1.
    Ang LP, Chua JL, Tan DT (2007) Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol 18(4):308–313PubMedCrossRefGoogle Scholar
  2. 2.
    Gupta VP, Saxena T (2003) Comparison of single-drop mitomycin C regime with other mitomycin C regimes in pterygium surgery. Indian J Ophthalmol 51:59–65PubMedGoogle Scholar
  3. 3.
    Mahar PS, Manzar N, Ahmad K (2011) The effect of intra-operative use of topical mitomycin-C on intra-ocular pressure in patients with pterygium excision. Asian J Ophthalmol 12:144–148Google Scholar
  4. 4.
    D’Ombrain A (1948) The surgical treatment of pterygium. Br J Ophthalmol 32:65–71PubMedCrossRefGoogle Scholar
  5. 5.
    Hirst LW (2003) The treatment of pterygium. Surv Ophthalmol 48(2):145–180PubMedCrossRefGoogle Scholar
  6. 6.
    Mutlu FM, Sobaci G, Tatar T, Yildirim E (1999) A comparative study of recurrent pterygium surgery: limbal conjunctival autograft transplantation versus mitomycin C with conjunctival flap. Ophthalmology 106:817–821PubMedCrossRefGoogle Scholar
  7. 7.
    Sharma A, Gupta A, Ram J, Gupta A (2000) Low-dose intraoperative mitomycin-C versus conjunctival autograft in primary pterygium surgery: long term follow-up. Ophthalmic Surg Lasers 31:301–307PubMedGoogle Scholar
  8. 8.
    Kunitomo N, Mori S (1963) Studies on the pterygium. Part 4. A treatment of the pterygium by mitomycin C instillation. Acta Soc Ophthalmol Jpn 67:601–607Google Scholar
  9. 9.
    Singh G, Wilson MR, Foster CS (1988) Mitomycin eye drops as treatment for pterygium. Ophthalmology 95:813–821PubMedCrossRefGoogle Scholar
  10. 10.
    Mahar PS, Manzar N, Hassan M, Ahmad T (2010) The effect of sub-conjunctival mitomycin-C on intra-ocular pressure in various types of glaucoma. Asian J Ophthalmol 12:2–6Google Scholar
  11. 11.
    Oguz H, Basar E, Gurler B (1999) Intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Acta Ophthalmol Scand 77(2):147–150PubMedCrossRefGoogle Scholar
  12. 12.
    Hata T, Hoshi T, Kanamori K, Matsumae A, Shima T, Sugawara R (1956) Mitomycin, a new antibiotic from Streptomyces. I. J Antibiot (Tokyo) 9(4):141–146Google Scholar
  13. 13.
    Qing-feng L, Liang X, Xiu-ying J, Qi-sheng Y, Xiao-hui Y, Tong-tong C (2010) Epidemiology of pterygium in aged rural population of Beijing, China. Chin Med J 123(13):1699–1701Google Scholar
  14. 14.
    Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR (2010) The science of pterygia. Br J Ophthalmol 94(7):815–820PubMedCrossRefGoogle Scholar
  15. 15.
    Gazzard G, Saw SM, Farook M, Koh D, Widjaja D, Chia SE et al (2002) Pterygium in Indonesia: prevalence, severity and risk factors. Br J Ophthalmol 86(12):1341–1346PubMedCrossRefGoogle Scholar
  16. 16.
    Mahar PS, Nwokora GE (1993) Role of mitomycin-C in pterygium surgery. Br J Ophthalmol 77:433–435PubMedCrossRefGoogle Scholar
  17. 17.
    Hayasaka S, Noda S, Yamamoto Y et al (1988) Postoperative instillation of low dose mitomycin-C in the treatment of primary pterygium. Am J Ophthalmol 106:715–718PubMedCrossRefGoogle Scholar
  18. 18.
    Rachmiel R, Leibe H, Levartovsky S (1995) Results of treatment with topical mitomycin C 0.02 % following excision of primary pterygium. Br J Ophthalmol 79:233–239PubMedCrossRefGoogle Scholar
  19. 19.
    Panda A, Das GK, Tuli SW, Kumar A (1998) Randomized trial of intra-operative mitomycin C in surgery for pterygium. Am J Ophthalmol 125:59–63PubMedCrossRefGoogle Scholar
  20. 20.
    Lam DS, Wong AK, Fan DS, Chew S, Kwok PS, Tso MO (1998) Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology 105(5):901–904PubMedCrossRefGoogle Scholar
  21. 21.
    Rahman A, Yahya K, Shariful Hasan K (2008) Recurrence rate of pterygium following surgical excision with intraoperative versus postoperative mitomycin-C. J Coll Physicians Surg Pak 18(8):489–492PubMedGoogle Scholar
  22. 22.
    Cheng HC, Tseng SH, Kao PL, Chen FK (2001) Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery. Cornea 20(1):24–29PubMedCrossRefGoogle Scholar
  23. 23.
    Narsani AK, Jatoi SM, Gul S, Dabir SA (2008) Treatment of primary pterygium with conjunctival autograft and mitomycin C. A comparative study. J Liaquat Uni Med Health Sci 7(3):184–187Google Scholar
  24. 24.
    Frucht-pery J, Raiskup F, Ilsar M, Landau D, Orucov F, Solomon A (2006) Conjunctival autografting combined with low-dose mitomycin C for prevention of primary pterygium recurrence. Am J Ophthalmol 141(6):1044–1050PubMedCrossRefGoogle Scholar
  25. 25.
    Mahar PS (1997) Conjunctival autograft versus topical mitomycin C in treatment of pterygium. Eye 11:790–792PubMedCrossRefGoogle Scholar
  26. 26.
    Chen PP, Ariyasu RG, Kaza V, LaBree LD, McDonnell PJ (1995) A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol 120(2):151–160PubMedGoogle Scholar
  27. 27.
    Mastropasqua L, Carpineto P, Ciancaglini M et al (1996) Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. Br J Ophthalmol 80:288–291PubMedCrossRefGoogle Scholar
  28. 28.
    Mahar PS (1996) Role of mitomycin-C in reducing the recurrence of pterygium after surgery. Pak J Ophthalmol 12(3):91–94Google Scholar
  29. 29.
    Díaz L, Villegas VM, Emanuelli A, Izquierdo NJ (2008) Efficacy and safety of intraoperative mitomycin C as adjunct therapy for pterygium surgery. Cornea 27(10):1119–1121PubMedCrossRefGoogle Scholar
  30. 30.
    Tan DTH, Chee SP, Dear KBG et al (1997) Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 115:1235–1240PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  1. 1.Section of Ophthalmology, Department of SurgeryAga Khan University HospitalKarachiPakistan
  2. 2.Dow University of Health SciencesKarachiPakistan

Personalised recommendations